Genoa Ventures
Genoa Ventures is a venture capital firm that invests in early-stage life sciences technology companies.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Genoa Ventures Information
Geographic Data
Address: 3215 21st St
City: San Francisco
State: CA
Zip: 94110
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$84M
Social
Twitter
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Genoa Ventures invests in early-stage life sciences technology companies. They fund entrepreneurs and companies looking to change the way science gets done with new tools and technologies. Sector focus areas include research tools, molecular diagnostics, synthetic biology, and industrial biology. Genoa Ventures was founded in 2014 by Jenny Rooke and is based in San Francisco, California, United States.
Contact Phone:
+14155580050
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 9/2022 | Bond Pet Foods | Series A | 0 |
| 2/2022 | Epitel | Series A | 0 |
| 9/2020 | Ionpath | Series B | 0 |
| 12/2020 | BRAINBox Solutions | Series A | 23M |
| 4/2021 | Attune Neurosciences | Seed Round | 3.8M |
| 6/2020 | Tropic Biosciences | Series B | 0 |
| 6/2018 | Mission Bio | Venture Round | - |
| 4/2022 | Codetta Biosciences | Series A | 15M |
| 8/2021 | InterVenn | Series C | 0 |
| 12/2018 | InterVenn | Venture Round | 0 |
| 3/2016 | Pivot Bio | Series A | 16M |
| 12/2022 | BrightSpec | Series C | 18.4M |
| 11/2020 | InterVenn | Series B | 0 |
| 3/2015 | Caribou Biosciences | Series A | 0 |
| 6/2015 | Zymergen | Series A | 42.1M |
| 1/2014 | Zymergen | Seed Round | 2M |
| 1/2017 | Synthomics | Seed Round | - |
| 12/2021 | Meiogenix | Series A | 12.4M |
| 7/2021 | BloodQ | Seed Round | 4.5M |
| 1/2018 | Ionpath | Series A | - |
| 9/2014 | Zephyrus Biosciences | Seed Round | 1.5M |
| 9/2017 | Akadeum Life Sciences | Venture Round | 1.5M |
| 2/2020 | Intabio | Series B | 18M |
| 10/2021 | SimBioSys | Series A | 0 |
| 10/2018 | Intabio | Series A | 9.5M |
| 7/2021 | Stemson Therapeutics | Series A | 0 |
| 11/2017 | NanoCellect Biomedical | Series B | 0 |
| 5/2016 | Caribou Biosciences | Series B | 30M |
| 9/2017 | Intabio | Seed Round | 2M |
| 10/2015 | Ionpath | Seed Round | - |
| 1/2017 | Adarza BioSystems | Series C | 17M |
| 9/2022 | ZwitterCo | Series A | 0 |
| 4/2022 | Codetta Biosciences | Series A | 0 |
| 2/2022 | Epitel | Series A | 0 |
| 12/2021 | Meiogenix | Series A | 0 |
| 10/2021 | SimBioSys | Series A | 0 |
| 8/2021 | InterVenn | Series C | 0 |
| 7/2021 | Stemson Therapeutics | Series A | 0 |
| 7/2021 | BloodQ | Seed Round | 0 |
| 4/2021 | Attune Neurosciences | Seed Round | 0 |
| 12/2020 | BRAINBox Solutions | Series A | 0 |
| 11/2020 | InterVenn | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
